Información de la revista
Compartir
Descargar PDF
Más opciones de artículo
Original article
Efficacy and safety of rituximab for childhood refractory nephrotic syndrome: A meta-analysis of randomized controlled trials
Eficacia y seguridad de rituximab para el síndrome nefrótico refractario infantil: un meta-análisis de ensayos controlados aleatorios
Dan Changa, Minmin Gongb, Chaofan Liub, Quan Zhangb, Ziwei Hub, Zhuoguang Lic,
Autor para correspondencia
a Department of Nephrology, University of Electronic Science and Technology, Sichuan Academy of Sciences & Sichuan Provincial People's Hospital, Chengdu 610072, Sichuan China
b Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
c Department of Endocrinology, Shenzhen Children's Hospital, Shenzhen 518038, China
Artículo
This article is available in English
Efficacy and safety of rituximab for childhood refractory nephrotic syndrome: A meta-analysis of randomized controlled trials
Dan Chang, Minmin Gong, Chaofan Liu, Quan Zhang, Ziwei Hu, Zhuoguang Li
10.1016/j.medcle.2020.07.048Med Clin. 2021;157:418-26